Thus, we adopted shRNA-mediated XRCC2 silencing strategy to investigate the effect of XRCC2 silencing on cell growth and sensitization to X-radiation in colon cancer in vitro and in vivo. This evidence concerns the gene XRCC2 and colonic neoplasm.